What cannabidiol oil actually is and whether you should consider using it ...
Artelo continues preparations to initiate a Phase 1 multiple ascending dose study in the fourth quarter of 2026. First-in-human data showed favorable safety and tolerability, linear and ...
More research is needed about the two most prominent compounds in marijuana. Here's what we know so far.
CHARLOTTE, N.C., Aug. 13, 2026 /PRNewswire/ -- cbdMD, Inc. (NYSE American: YCBD), one of the nation's leading and most trusted CBD companies and operator of the cbdMD, Bluebird Botanicals, and Paw CBD ...
What physicians need patients to understand about cannabidiol products ...
New research — which Kentucky participated in as a trial site — shows a combination of cannabidiol (CBD) and ...
New research — which Kentucky participated in as a trial site — shows a combination of cannabidiol (CBD) and ...
Daily cannabis use is surging as potency quadruples. An ER doctor explains the real risks: addiction, withdrawal, psychosis, heart disease, and lung cancer.
Jazz Pharmaceuticals stock buys Actio Biosciences for $820 million to boost the KCNT1 epilepsy pipeline as Q2 2026 hits $1.2 ...